Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 61 trials
Active filters
Clinical trials found
Published and searchable clinical trials
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
NCT05006716
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- Mayo Clinic Phoenix Phoenix, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
NCT06986174
- Conditions
- B-Cell Lymphoproliferative Disorder, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
NCT02362035
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Denver, Colorado, United States
- Research Site Washington D.C., District of Columbia, United States
NCT01384513
- Conditions
- Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +111 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT02213913
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +104 more
- Locations
-
- Rush University Medical Center Chicago, Illinois, United States
- University of Chicago Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
- NorthShore University HealthSystem Evanston, Illinois, United States
NCT01588015
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia
NCT03187262
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma
NCT02049541
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +28 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
NCT02037256
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +130 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
NCT00536601
- Conditions
- Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +137 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01258998
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +82 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00918333
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00040846
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +164 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +250 more
- Locations
-
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00014235
- Conditions
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +159 more
- Locations
-
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
- Conditions
- Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy
NCT00078858
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +220 more
- Locations
-
- Stanford University Hospitals and Clinics Stanford, California, United States
- Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +87 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- Universitaet Leipzig Leipzig, Germany
NCT00856388
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +179 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00005799
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- University of Colorado Denver, Colorado, United States
- Baylor University Medical Center Dallas, Texas, United States